Eikon Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/AEikon Therapeutics, Inc.EIKNOct 8

   Eikon Therapeutics, Inc. (EIKN) reports major shareholder

   • FMR LLC owns 10.2% of Eikon Therapeutics
   • Abigail P. Johnson owns 10.2% of Eikon Therapeutics
   • FMR LLC and Abigail P. Johnson filed Schedule 13G on 2026-10-07

   FMR LLC, filed by

2. ROUTINESCHEDULE 13G/AEikon Therapeutics, Inc.EIKNOct 2

   Eikon Therapeutics, Inc. shares held by ADIA

   • Abu Dhabi Investment Authority holds 1,147,138 shares
   • Platinum Falcon B 2018 RSC Limited holds 1,147,138 shares
   • Total ownership is 2.1% of outstanding shares

   Abu Dhabi Investment Authority

3. ROUTINE4Eikon Therapeutics, Inc.EIKNSep 8

   Peter Svennilson, insider filing for EIKN

   Peter Svennilson, reporting · Tim Kutzkey, reporting · +6 more

4. ROUTINE8-KEikon Therapeutics, Inc.EIKNAug 14

   Current report

5. NOTABLE10-QEikon Therapeutics, Inc.EIKNAug 13

   Quarterly report

6. ROUTINE8-KEikon Therapeutics, Inc.EIKNAug 13

   Current report

7. ROUTINESCHEDULE 13G/AEikon Therapeutics, Inc.EIKNAug 6

   Ownership stake disclosure by FMR LLC (amended)

   FMR LLC, filed by

8. ROUTINE8-KEikon Therapeutics, Inc.EIKNAug 3

   Current report

9. ROUTINE3Eikon Therapeutics, Inc.EIKNJun 15

   Ma. Fatima Francisco, new insider at EIKN

   Ma. Fatima Francisco, reporting

10. ROUTINE8-KEikon Therapeutics, Inc.EIKNJun 10

    Current report

11. ROUTINE8-KEikon Therapeutics, Inc.EIKNJun 1

    Current report

12. ROUTINESCHEDULE 13GEikon Therapeutics, Inc.EIKNMay 15

    Ownership stake disclosure by Innovation Endeavors III LP

    Innovation Endeavors III LP, filed by

13. ROUTINESCHEDULE 13GEikon Therapeutics, Inc.EIKNMay 13

    Ownership stake disclosure by Roger M Perlmutter

    Roger M Perlmutter, filed by

14. NOTABLE10-QEikon Therapeutics, Inc.EIKNMay 11

    Quarterly report

15. ROUTINE8-KEikon Therapeutics, Inc.EIKNMay 11

    Current report

16. ROUTINESCHEDULE 13GEikon Therapeutics, Inc.EIKNMay 6

    Ownership stake disclosure by FMR LLC

    FMR LLC, filed by

17. ROUTINESCHEDULE 13GEikon Therapeutics, Inc.EIKNApr 29

    Ownership stake disclosure by BlackRock Portfolio Management LLC

    BlackRock Portfolio Management LLC, filed by

18. ROUTINE8-KEikon Therapeutics, Inc.EIKNMar 30

    Current report

19. NOTABLE10-KEikon Therapeutics, Inc.EIKNMar 30

    Annual report

20. ROUTINE4Eikon Therapeutics, Inc.EIKNMar 4

    7 insider filings

    Michael A Klobuchar, insider filing for EIKN

    Show all 7

    • 4Insider filing for EIKNMar 4
    • 4Insider filing for EIKNMar 4
    • 4Insider filing for EIKNMar 4
    • 4Insider filing for EIKNMar 4
    • 4Insider filing for EIKNMar 4
    • 4Insider filing for EIKNMar 4
    • 4Insider filing for EIKNMar 4

    Michael A Klobuchar, reporting

21. ROUTINESCHEDULE 13GEikon Therapeutics, Inc.EIKNFeb 18

    Ownership stake disclosure by Abu Dhabi Investment Authority

    Abu Dhabi Investment Authority, filed by

22. NOTABLESCHEDULE 13DEikon Therapeutics, Inc.EIKNFeb 12

    Ownership stake disclosure by Column Group IV GP, LP

    Column Group IV GP, LP, filed by

23. ROUTINESCHEDULE 13GEikon Therapeutics, Inc.EIKNFeb 11

    Ownership stake disclosure by Foresite Capital Fund IV, L.P.

    Foresite Capital Fund IV, L.P., filed by

24. ROUTINE4Eikon Therapeutics, Inc.EIKNFeb 10

    Roger M Perlmutter, insider filing for EIKN

    Roger M Perlmutter, reporting

25. ROUTINE4Eikon Therapeutics, Inc.EIKNFeb 9

    Peter Svennilson, insider filing for EIKN

    Peter Svennilson, reporting · Tim Kutzkey, reporting · +6 more

26. ROUTINE4Eikon Therapeutics, Inc.EIKNFeb 6

    Foresite Capital Fund IV, L.P., insider filing for EIKN

    Foresite Capital Fund IV, L.P., reporting · Foresite Capital Management IV, LLC, reporting · +6 more

27. ROUTINE4Eikon Therapeutics, Inc.EIKNFeb 6

    3 insider filings

    Kenneth C Frazier, insider filing for EIKN

    Show all 3

    • 4Insider filing for EIKNFeb 6
    • 4Insider filing for EIKNFeb 6
    • 4Insider filing for EIKNFeb 6

    Kenneth C Frazier, reporting

28. ROUTINES-8Eikon Therapeutics, Inc.EIKNFeb 6

    Employee stock plan registration

29. ROUTINE8-KEikon Therapeutics, Inc.EIKNFeb 6

    Current report

30. ROUTINE424B4Eikon Therapeutics, Inc.EIKNFeb 5

    Securities offering

31. ROUTINE3Eikon Therapeutics, Inc.EIKNFeb 4

    12 insider filings

    Column Group IV-A, LP, new insider at EIKN

    Show all 12

    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4
    • 3New insider at EIKNFeb 4

    Column Group IV-A, LP, reporting · Column Group IV GP, LP, reporting · +3 more

Older filings on EDGAR